Jun 19, 2008 - Covidien (NYSE: COV, BSX: COV), a leading global healthcare products company, announced the latest advance in its "Unite to Treat Sleep Apnea" initiative, an integrated program connecting physicians, sleep labs, treatment providers and patients to improve the diagnosis and treatment of those afflicted with obstructive sleep apnea. The Company is now partnering with Sleep Pointe, an organization dedicated to providing sleep apnea management and wellness programs within the transportation industry.
Covidien created the "Unite to Treat Sleep Apnea" initiative in response to the increased demand for sleep apnea treatment. According to the National Institutes of Health, approximately 12 million Americans suffer from sleep apnea, and an additional 10 million remain undiagnosed... Sleep Pointe's Press Release -
